These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8370766)
1. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease. Koh CS; Gausas J; Paterson PY J Neuroimmunol; 1993 Sep; 47(2):141-5. PubMed ID: 8370766 [TBL] [Abstract][Full Text] [Related]
2. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. Koh CS; Gausas J; Paterson PY J Neuroimmunol; 1992 May; 38(1-2):85-93. PubMed ID: 1577954 [TBL] [Abstract][Full Text] [Related]
3. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Paterson PY Fed Proc; 1976 Nov; 35(13):2428-34. PubMed ID: 61895 [TBL] [Abstract][Full Text] [Related]
4. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats. Inoue A; Koh CS; Shimada K; Yanagisawa N; Yoshimura K J Neuroimmunol; 1996 Dec; 71(1-2):131-7. PubMed ID: 8982112 [TBL] [Abstract][Full Text] [Related]
5. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor. Koh CS; Paterson PY Cell Immunol; 1987 Jun; 107(1):52-63. PubMed ID: 2438054 [TBL] [Abstract][Full Text] [Related]
6. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Juhler M; Barry DI; Offner H; Konat G; Klinken L; Paulson OB Brain Res; 1984 Jun; 302(2):347-55. PubMed ID: 6610460 [TBL] [Abstract][Full Text] [Related]
7. Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis. Koh CS; Kwaan HC; Paterson PY J Neuroimmunol; 1990 Aug; 28(3):189-200. PubMed ID: 2373760 [TBL] [Abstract][Full Text] [Related]
8. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE. Matsumoto Y; Fujiwara M J Neurol Sci; 1987 Jan; 77(1):35-47. PubMed ID: 2433404 [TBL] [Abstract][Full Text] [Related]
9. Demyelination and early remyelination in experimental allergic encephalomyelitis passively transferred with myelin basic protein-sensitized lymphocytes in the Lewis rat. Pender MP; Nguyen KB; Willenborg DO J Neuroimmunol; 1989 Dec; 25(2-3):125-42. PubMed ID: 2479658 [TBL] [Abstract][Full Text] [Related]
10. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis. Rousseau V; Denizot B; Le Jeune JJ; Jallet P Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016 [TBL] [Abstract][Full Text] [Related]
11. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. Juhler M; Blasberg RG; Fenstermacher JD; Patlak CS; Paulson OB J Cereb Blood Flow Metab; 1985 Dec; 5(4):545-53. PubMed ID: 3877064 [TBL] [Abstract][Full Text] [Related]
12. Role of the clotting system in the pathogenesis of neuroimmunologic disease. Paterson PY; Koh CS; Kwaan HC Fed Proc; 1987 Jan; 46(1):91-6. PubMed ID: 2433164 [TBL] [Abstract][Full Text] [Related]
13. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Meeson AP; Piddlesden S; Morgan BP; Reynolds R Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334 [TBL] [Abstract][Full Text] [Related]
14. Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine. Paul C; Bolton C J Pharmacol Exp Ther; 2002 Jul; 302(1):50-7. PubMed ID: 12065699 [TBL] [Abstract][Full Text] [Related]
15. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis. Matsuda M; Tsukada N; Koh CS; Iwahashi T; Shimada K; Yanagisawa N Autoimmunity; 1994; 19(1):15-22. PubMed ID: 7749038 [TBL] [Abstract][Full Text] [Related]
16. Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat. Daniel PM; Lam DK; Pratt OE J Neurol Sci; 1983; 60(3):367-76. PubMed ID: 6415240 [TBL] [Abstract][Full Text] [Related]
17. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis. Orr EL; Stanley NC J Neurochem; 1989 Jul; 53(1):111-8. PubMed ID: 2786054 [TBL] [Abstract][Full Text] [Related]
19. The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat. Huang XN; Wang WZ; Fu J; Wang HB Anat Rec (Hoboken); 2011 Jan; 294(1):46-54. PubMed ID: 21157915 [TBL] [Abstract][Full Text] [Related]
20. The distribution of immunoglobulins and albumin in the central nervous system in acute experimental allergic encephalomyelitis. Juhler M; Laursen H; Barry DI Acta Neurol Scand; 1986 Feb; 73(2):119-24. PubMed ID: 3518328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]